Printer Friendly

VESTAR INC. FILES PROPOSED PUBLIC OFFERING OF 2,500,000 SHARES OF COMMON STOCK

 VESTAR INC. FILES PROPOSED PUBLIC OFFERING OF
 2,500,000 SHARES OF COMMON STOCK
 SAN DIMAS, Calif., Dec. 24 /PRNewswire/ -- Vestar Inc. (NASDAQ: VSTR) today filed a Registration Statement with the Securities and Exchange Commission concerning a proposed public offering of 2,500,000 shares of common stock, all of which will be sold by the company. In addition, the company will grant the underwriters an option to purchase up to an additional 375,000 shares to cover any over-allotments.
 This offering will be managed by Alex. Brown & Sons Inc.
 Vestar develops, manufactures and markets pharmaceuticals to treat patients with cancer and serious infections, including AIDS.
 Copies of the preliminary prospectus will be available in mid- January from Alex. Brown & Sons Inc., 135 East Baltimore St., Baltimore, 21202.
 A Registration Statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the Registration Statement becomes effective. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 -0- 12/24/91
 CONTACT: Michael E. Hart, CFO of Vestar Inc., 714-394-4119; or Marcia A. Kean, executive VP of Feinstein Partners Inc., 617-577-8110/
 (VSTR) CO: Vestar Inc. ST: California IN: SU:


EH -- LA002 -- 5150 12/24/91 11:59 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 24, 1991
Words:266
Previous Article:ONTARIO HYDRO HAS REJECTED DENISON'S MINES ESTIMATED BASE PRICE
Next Article:U S WEST CELLULAR TEAMS WITH THE SEATTLE TIMES INFOLINE; TOUCH OF CELLULAR PHONE PROVIDES INFORMATION, NEWS HOTLINE
Topics:


Related Articles
ISIS PHARMACEUTICALS FILES PUBLIC OFFERING FOR 2.5 MILLION SHARES OF COMMON STOCK
NPS PHARMACEUTICALS, INC. FILES INITIAL PUBLIC OFFERING REGISTRATION STATEMENT
GELTEX FILES FOR INITIAL PUBLIC OFFERING OF 2,500,000 SHARES OF COMMON STOCK
ERGO SCIENCE FILES REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING OF 2,500,000 SHARES OF COMMON STOCK
DIATIDE, INC. FILES REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING OF 2,500,000 SHARES OF COMMON STOCK
AGOURON PHARMACEUTICALS FILES PUBLIC OFFERING FOR 2.5 MILLION SHARES OF COMMON STOCK
CV Therapeutics, Inc. Files Initial Public Offering Registration Statement
Maxim Files Registration Statement to Issue 2,500,000 Additional Shares of Common Stock
Abgenix Files Common Stock Offering of Up to 2.5 Million Shares.
Biopure Corporation Announces Proposed Common Stock Offering.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters